Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IBC 2024 | Non-drug interventions in SMM/MGUS: diet & lifestyle

Urvi Shah • 25 Mar 2024
IBC 2024
Multiple Myeloma Rare Diseases Smoldering Myeloma
NUTRIVENTION

Urvi Shah, MD, Memorial Sloan Kettering Cancer Center, New York City, NY, shares insights into her work exploring non-drug interventions for smoldering multiple myeloma (SMM) and monoclonal gammopathy of undetermined significance (MGUS). Dr Shah discusses the link between various dietary patterns and the risk of developing multiple myeloma, and gives an overview of ongoing studies in this space, including the NUTRIVENTION-3 trial (NCT05640843). This session was filmed at IBC 2024, held in Lisbon, Portugal.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Urvi Shah

1:38
Correlation between extreme BMI and survival in patients with multiple myeloma
Urvi Shah • 24 Apr 2023
2:37
Dietary and microbiome evidence in myeloma & other plasma cell disorders
Urvi Shah • 24 Apr 2023
2:43
The value of exploring lifestyle medicine in hematology
Urvi Shah • 24 Apr 2023
5:45
Diet-microbiome interactions in oncology and the importance of investigating this
Urvi Shah • 24 Apr 2023

Related Videos

1:15
Using MRD to guide treatment decisions in myeloma
Karthik Ramasamy • 28 Apr 2024
0:46
The urgency of diagnosing and treating patients with Castleman disease
Karthik Ramasamy • 28 Apr 2024
0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals